Two consecutive phase II window trials of irinotecan alone or in combination with vincristine for the treatment of metastatic rhabdomyosarcoma: the Children's Oncology Group.

Source:http://linkedlifedata.com/resource/pubmed/id/17264331

J. Clin. Oncol. 2007 Feb 1 25 4 362-9

Download in:

View as

General Info

PMID
17264331